Internal Medicine · Austin, TX
NPI
1194730242
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
11111 Research Blvd #475
Austin, TX, 78759
Phone (512) 338-8181
Medicare paid, 2024
$26K
1,010 services
Medicare patients, 2024
154
Average age 72
Drug cost, 2024
$467K
1,134 prescriptions
Company payments, 2025
$17.5
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maya B Bledsoe was code 84443 (clinical chemistry), 227 times for 121 patients. In total Maya B Bledsoe billed 1,010 services in 27 codes, and Medicare paid $26K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-11-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 84443 Clinical Chemistry | Office | 227 | 121 | $16.27 | $3,694 |
| 99214 Office E&M - Established | Office | 151 | 131 | $80.69 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 150 | 127 | $11.16 | $1,674 |
| 82306 Clinical Chemistry | Office | 121 | 97 | $28.24 | $3,417 |
| 84439 Clinical Chemistry | Office | 84 | 47 | $8.77 | $736 |
| 80053 Clinical Chemistry | Office | 74 | 53 | $10.24 | $758 |
| 84481 Clinical Chemistry | Office | 43 | 22 | $16.60 | $714 |
| 85025 Blood Count | Office | 37 | 27 | $7.58 | $280 |
| 83735 Clinical Chemistry | Office | 25 | 25 | $7.47 | $187 |
| 83036 Blood Count | Office | 17 | 16 | $9.93 | $169 |
By year: 2022 $32K for 1,115 services; 2023 $25K for 867 services; 2024 $26K for 1,010 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 84443 Clinical Chemistry | 227 | 121 | $16.27 | $3,694 |
| 82306 Clinical Chemistry | 121 | 97 | $28.24 | $3,417 |
| 84439 Clinical Chemistry | 84 | 47 | $8.77 | $736 |
| 80053 Clinical Chemistry | 74 | 53 | $10.24 | $758 |
| 84481 Clinical Chemistry | 43 | 22 | $16.60 | $714 |
| 85025 Blood Count | 37 | 27 | $7.58 | $280 |
| 83735 Clinical Chemistry | 25 | 25 | $7.47 | $187 |
| 83036 Blood Count | 17 | 16 | $9.93 | $169 |
Medicare prescription drug claims, 2024
In 2024, the drug Maya B Bledsoe prescribed most often to Medicare patients was Levothyroxine Sodium, with 491 prescriptions and refills. In total Maya B Bledsoe wrote 1,134 Medicare prescriptions that cost $467K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 491 | 1,283 | 133 | $5,752 |
| Synthroid Levothyroxine Sodium | 432 | 1,056 | 120 | $42K |
| Hydrochlorothiazide Generic | 45 | 131 | 12 | $246 |
| Levoxyl Levothyroxine Sodium | 25 | 50 | Under 11 | $1,061 |
| Calcitriol Generic | 25 | 54 | Under 11 | $575 |
| Liothyronine Sodium Generic | 17 | 48 | Under 11 | $1,163 |
| Sandostatin Lar Depot Octreotide Acetate,mi-Spheres | 13 | 13 | Under 11 | $58K |
| Cabergoline Generic | 13 | 46 | Under 11 | $621 |
| Hydrocortisone Generic | 12 | 14 | Under 11 | $290 |
| Potassium Chloride Generic | 12 | 37 | Under 11 | $231 |
| Alendronate Sodium Generic | 12 | 33 | Under 11 | $126 |
| Somavert Pegvisomant | 11 | 11 | Under 11 | $352K |
Brand drugs: 636 claims; generic drugs: 498 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maya B Bledsoe $17.5 ($17.5 in general payments such as food, travel and fees) from 1 company. The largest payer was Minerva Surgical, Inc with $17.5.
| Company | Payments | Amount |
|---|---|---|
| Minerva Surgical, Inc UTRS | 1 | $17.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.